<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04054895</url>
  </required_header>
  <id_info>
    <org_study_id>LEVEL-AT</org_study_id>
    <nct_id>NCT04054895</nct_id>
  </id_info>
  <brief_title>LEft VEntricuLar Activation Time Shortening With Physiological Pacing vs Biventricular Resynchronization Therapy</brief_title>
  <acronym>LEVEL-AT</acronym>
  <official_title>LEft VEntricuLar Activation Time Shortening With Physiological Pacing vs Biventricular Resynchronization Therapy: a Randomized Study (LEVEL-AT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Josep Lluis Mont Girbau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut d'Investigacions Biomèdiques August Pi i Sunyer</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Clinic of Barcelona</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The LEVEL-AT Trial (LEft VEntricuLar Activation Time Shortening with Physiological Pacing vs
      Biventricular Resynchronization therapy: a randomized study) is a non-inferiority study that
      aims to determine if physiological pacing could decrease the left ventricular activation time
      compared with biventricular therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To date studies have showed that physiological pacing could get similar clinical and
      echocardiographic response to that obtained with biventricular therapy. Activation time
      shortening with permanent physiological pacing has not been studied.

      This study will randomize 70 patients to a strategy of: biventricular pacing versus
      physiological pacing.

      LEVEL-AT study will analyze the following parameters in the 2 groups: shortening of the QRS,
      activation time with electrocardiographic imaging, echocardiographic asynchrony and
      ventricular function and clinical parameters (NYHA functional class, mortality and heart
      failure hospitalization).

      Clinical, electrocardiographic, echocardiographic and electrocardiographic imaging follow-up
      will be performed for 1 year.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, unicentric, simple blind.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>The patient will be explained to be randomized to either of the two branches. The type of therapy applied will not be communicated to the patient. The follow-up will be the same in the two branches. During the visits it will not be said which therapy has been applied.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular activation time.</measure>
    <time_frame>45 days</time_frame>
    <description>Left ventricular activation time measured by eletrocardiographic imaging.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>QRS duration.</measure>
    <time_frame>Implant, 6 months and 12 months.</time_frame>
    <description>QRS duration (milliseconds) measured with a 12-lead ECG.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular activation time.</measure>
    <time_frame>6 months and 12 months.</time_frame>
    <description>Left ventricular activation time measured by eletrocardiographic imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in left ventricular function.</measure>
    <time_frame>6 months and 12 months.</time_frame>
    <description>Left ventricular ejection fraction measured with Simpson method with echocardiography.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in end-systolic volume.</measure>
    <time_frame>6 months and 12 months.</time_frame>
    <description>End-systolic volume measured with echocardiography.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in NYHA functional class.</measure>
    <time_frame>6 months and 12 months.</time_frame>
    <description>NYHA functional class I, II, III, IV.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization due to heart failure or mortality (combined endpoint).</measure>
    <time_frame>1 year.</time_frame>
    <description>Hospitalization: patient hospitalization (yes/no) Mortality: mortality (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correction of septal flash</measure>
    <time_frame>15 days</time_frame>
    <description>Correction of septal flash determined with echocardiography (M mode)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Physiological Pacing</condition>
  <condition>Resynchronization Therapy</condition>
  <arm_group>
    <arm_group_label>Physiological pacing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pacing the his-purkinje system.
Crossover to biventricular CRT will be allowed in the following situations: failed physiological pacing lead implantation; high thresholds (&gt;3.5V / 1ms); no shortening of QRS (shortening &lt;20%) or failure to meet non-selective HBP criteria [Europace. 2019 Oct 9. doi: 10.1093/europace/euz275].</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biventricular resynchronization therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pacing from the right ventricular and coronary sinus leads. Electrocardiographic optimization with fusion-optimized intervals.
Crossover from biventricular CRT to physiological pacing will be allowed in the following situations: coronary sinus cannot be cannulated; no lateral or posterolateral branches; or phrenic stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lead placed in the His-Purkinje system in order to achieve QRS shortening.</intervention_name>
    <description>Physiologic pacing to achieve QRS shortening. If the patient has indication of stimulation (AV block), a backup lead will be implanted in the right ventricle. All patients will have a lead placed in the right atrium (except those that have permanent atrial fibrillation).</description>
    <arm_group_label>Physiological pacing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lead is placed in a tributary of the coronary sinus.</intervention_name>
    <description>Biventricular Resynchronization Therapy is the use of a pacemaker with two endocardial leads placed in the right atrium and right ventricle. The third lead is placed in a tributary of the coronary sinus.</description>
    <arm_group_label>Biventricular resynchronization therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient must indicate their acceptance to participate in the study by signing an
             informed consent document.

          -  The patient must be ≥ 18 years of age.

          -  In sinus rhythm, left branch block, QRS ≥130 and FEVI &lt;=35% (Indication of cardiac
             resynchronization IA or IB ESC Guidelines). No indication of stimulation for AV block.

          -  Patients with indication of resynchronization therapy for ventricular dysfunction and
             indication of cardiac stimulation for AV block according to ESC Guidelines (IA ESC
             Guidelines).

          -  In sinus rhythm, without left branch block, QRS ≥150 and FEVI &lt;=35% (Indication of
             cardiac resynchronization IIaB ESC Guidelines).

        Exclusion Criteria:

          -  Myocardial infarction, unstable angina or cardiac revascularization during the
             previous 3 months.

          -  Pregnancy.

          -  Participating currently in a clinical investigation that includes an active treatment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose M Tolosana, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clínic de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Margarida Pujol Lopez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clínic de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lluis Mont Girbau, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Clínic de Barcelona</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Margarida Pujol Lopez, MD</last_name>
    <phone>93 2271778</phone>
    <email>mapujol@clinic.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jose M Tolosana, MD, PhD</last_name>
    <phone>93 2271778</phone>
    <email>tolosana@clinic.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <state>Select</state>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margarida Pujol Lopez</last_name>
      <email>mapujol@clinic.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>August 7, 2019</study_first_submitted>
  <study_first_submitted_qc>August 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2019</study_first_posted>
  <last_update_submitted>February 22, 2020</last_update_submitted>
  <last_update_submitted_qc>February 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clinic of Barcelona</investigator_affiliation>
    <investigator_full_name>Josep Lluis Mont Girbau</investigator_full_name>
    <investigator_title>Head of Arrhythmia Section. Professor of Cardiology</investigator_title>
  </responsible_party>
  <keyword>Physiological pacing</keyword>
  <keyword>Resynchronization therapy</keyword>
  <keyword>Electrocardiographic imaging</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

